HPRT mutations in humans: Biomarkers for mechanistic studies

Mutation Research - Reviews in Mutation Research

Volumn 489, Issue 1, 2001, Pages 1-16

  Albertini, Richard J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Biomarker; Genomic instability; HPRT mutations; Humans; Lesch Nyhan syndrome

Indexed keywords

CARCINOGEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MUTAGENIC AGENT; RECOMBINASE; T LYMPHOCYTE RECEPTOR;

CARCINOGENESIS; CELL PROLIFERATION; FIBROBLAST; GENE FUNCTION; GENE MUTATION; GERM CELL; HUMAN; LYMPHOCYTE CLONE; MUTAGENESIS; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SOMATIC CELL; SOMATIC MUTATION; T LYMPHOCYTE;

BIOLOGICAL MARKERS; CELL DIVISION; CLONE CELLS; DNA MUTATIONAL ANALYSIS; ENVIRONMENTAL EXPOSURE; FIBROBLASTS; GENES, REPORTER; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LESCH-NYHAN SYNDROME; MUTAGENS; MUTATION; PHENOTYPE; T-LYMPHOCYTES;

ANIMALIA;

EID: 0034769358     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(01)00064-3     Document Type: Review

References (103)

1. International Commission for Protection Against Environmental Mutagens and Carcinogens, Working Paper 3: Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo
2. Somatic mutations in cancer epidemiology
3. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis
4. A familial disorder of uric acid metabolism and central nervous system function
5. X-linked recessive inheritance of a syndrome of mental retardation with hyperuricemia
6. Genetics of an X-linked disorder of uric acid metabolism and cerebral function
7. Clinical features of the Lesch-Nyhan syndrome. Introduction - Clinical and genetic features. Seminars on the Lesch-Nyhan syndrome
8. Clinical features of the Lesch-Nyhan syndrome. Summary of clinical features. Seminars on the Lesch-Nyhan syndrome
9. Utilisation of purines by an HPRT variant in an intelligent, non-mutilative patient with features of the Lesch-Nyhan syndrome
10. The spectrum of hypoxanthine guanine phosphoribosyltransferase deficiency
11. The spectrum of HPRT deficiency: An update
12. Enzymology and biochemistry. B. Aspects of purine metabolism
13. Enzymology and biochemistry. A. HG-PRT deficiency in the Lesch-Nyhan syndrome and gout
14. An enzymatic basis for variation in response to allopurinol
15. Genetic studies of HG-PRT deficiency and the Lesch-Nyhan syndrome with cultured human cells
16. Biochemistry and pharmacology of purine analogs
17. Genetics of somatic mammalian cells. VII. Induction and isolation of nutritional mutants in Chinese hamster cells
18. Mammalian cell genetics. II. Chemical induction of specific locus mutations in Chinese hamster cells in vitro
19. Purine requirement of cells cultured from humans affected with Lesch-Nyhan syndrome (hypoxanthine-guanine phosphoribosyltransferase deficiency)
20. Genetics of human cell lines. I. 8-Azaguanine resistance, a selective single step marker
21. Metabolic cooperation between biochemically marked mammalian cells in tissue culture
22. Diploid azaguanine-resistant mutants of cultured human fibroblasts
23. Detection and quantification of X-ray induced mutation in cultured, diploid fibroblasts
24. Localization of loci for HPRT and glucose-6-phosphate dehydrogenase and biochemical evidence for non-random X-chromosome expression from studies of a human X-autosome translocation
25. Human hypoxanthine-guanine phosphoribosyltransferase. Complete amino acid sequence of the erythrocyte enzyme
26. Isolation and characterisation of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase
27. Fine structure of the human hypoxanthine phosphoribosyltransferase gene
28. Organisation of the HPRT gene and related sequences in the human genome
29. Gene action in the X-chromosome of the mouse (Mus musculus L.)
30. Lyon hypothesis and X-linked disease
31. Single allele expression at an X-linked hyperuricemia locus in heterozygous human cells
32. Hypoxanthine-guanine phosphoribosyltransferase deficiency: Hererozygote has two clonal populations
33. Detection of females heterozygous for the Lesch-Nyhan mutation by 8-azaguanine-resistant growth of cultured fibroblasts
34. HG-PRT deficiency: Clinical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygous cultures
35. Expression of two X-linked genes in human hair follicles of double heterozygotes
36. Absence of mosaicism in the lymphocyte in X-linked congenital hyperurosemia
37. Epidemiology and genetic implications. Inheritance of HG-PRT deficiency and detection of heterozygotes
38. Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch-Nyhan syndrome
39. Mosaicism of peripheral blood lymphocyte populations in females heterozygous for the Lesch-Nyhan mutation
40. 6-Thioguanine resistant lymphocytes in human peripheral blood
41. Enumeration of 6-thioguanine resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo
42. Human somatic cell mutation: In vivo variant lymphocyte frequencies determined by 6-thioguanine resistant lymphocytes
43. T cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood
44. Measurement of the in vivo mutations in human lymphocytes
45. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes
46. An analysis of in vivo hprt mutant frequency in circulating T lymphocytes in the normal human population: A comparison of four databases
47. Determination of HPRT mutant frequencies in T lymphocytes from a healthy pediatric population: Statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age
48. Frequencies of HPRT-lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors
49. Increased somatic cell mutant frequency in atomic bomb survivors
50. Elevated frequencies of hypoxanthine phosphorybosyltransferase lymphocyte mutants are detected in Russian liquidators 6 to 10 years after exposure to radiation from the Chernobyl nuclear power plant accident
51. Elevated frequencies of 6-thioguanine resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: A prospective study
52. Factors influencing mutation at the hprt locus in T lymphocytes: Studies in normal women and women with benign and malignant breast masses
53. Biological and chemical monitoring of occupational exposure to ethylene oxide
54. Why use somatic mutations for human biomonitoring?
55. In vitro induction, expression and selection of thioguanine resistant mutants with human T lymphocytes
56. Analysis of mutations occurring at the human HPRT locus
57. Software for the analysis of mutations at the human HPRT gene
58. Russian mutational spectrum differs from that of their Western counterparts
59. Molecular analyses of in vivo hprt mutations in human T lymphocytes. I. Studies of low frequency spontaneous mutants by Southern blots
60. Molecular analyses of in vivo hprt mutations in human T-lymphocytes. IV. Studies in newborns
61. Somatic generation of antibody diversity
62. VDJ recombination
63. The mechanism of V(D)J joining: Lessons from molecular, immunological and comparative analyses
64. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T cells
65. Molecular analysis of in vivo hprt mutations in human lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT)
66. In vivo ionizing irradiations produce deletions in the hprt gene of human T lymphocytes
67. Southern blot analyses of human T lymphocyte mutants induced in vitro by gamma irradiation
68. Radiation quality affects efficiency of induction and molecular spectrum of hprt mutations in human T cells
69. Somatic mutations as multipurpose biomarkers
70. A common mechanism of chromosomal translocation in T and B cell neoplasia
71. The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors
72. Chromosomal translocations in lymphoid neoplasia: A reappraisal of the recombinase model
73. Site-specified deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor lineage: T cell receptor gene deletion mechanisms affect multiple genes
74. Development of human T lymphocytes and their thymus-dependency
75. V(D)J recombinase-mediated deletion of the hprt gene in T lymphocytes from adult humans
76. Kinds and locations of mutations induced in the hypoxanthine phosphoribosyltransferase gene of human T lymphocytes by 1-nitrosopyrene, including those caused by V(D)J recombinase
77. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of HPRT
78. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke
79. Impact of maternal lifestyle factors on newborn HPRT mutant frequencies and molecular spectrum - Initial results from the pre-natal exposures and pre-eclampsia prevention (PEPP) study
80. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies
81. BCL2 translocation frequency rises with age in humans
82. Use of T cell receptor gene probes to quantify the in vivo hprt mutations in human T lymphocytes
83. Molecular analyses of in vivo hypoxanthine phosphoribosyltransferase mutations in human T lymphocytes. II. Demonstration of a clonal amplification of hprt mutant T lymphocytes in vivo
84. - T cell subset contains specialized primed T cells
85. T cells responsive to myelin basic protein in patients with multiple sclerosis
86. Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis
87. Longitudinal study of frequency of HPRT mutant T cells in patients with multiple sclerosis
88. HPRT mutant T cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides
89. Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus
90. Assessment of clinical parameters associated with increased frequency of mutant T cells in patients with systemic lupus erythematosus
91. Increased frequency of mutations in the HPRT gene of T cells isolated from patients with anti-U1-70 kD autoantibody-positive connective tissue disease
92. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: Further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases
93. In vivo mutant frequency of thioguanine-resistant T cells in the peripheral blood and lymph nodes of melanoma patients
94. HPRT mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis
95. -) T cells in the peripheral blood of cardiac transplant recipients: A non-invasive technique for the diagnosis of allograft rejection
96. Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus
97. Genetic instability in human T lymphocytes
98. Temporal delineation of sequential HPRT mutations arising in vivo in a T cell clone with a mutator phenotype
99. Emergence of genetic instability in children treated for leukemia
100. Spontaneous mutators in bacteria: Insights into pathways of mutagenesis and repair
101. Proliferation of mutators in a cell population
102. Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress
103. Azathioprine